These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19696702)
1. Photodynamic therapy with verteporfin for avascular serous pigment epithelial detachment in elderly Koreans. Kim KS; Lee WK Retina; 2010 Jan; 30(1):93-9. PubMed ID: 19696702 [TBL] [Abstract][Full Text] [Related]
2. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Goto S; Gomi F; Ueno C; Nishida K Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480 [TBL] [Abstract][Full Text] [Related]
3. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy. Arif F; Pryds A; Larsen M Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489 [TBL] [Abstract][Full Text] [Related]
4. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Saito M; Iida T; Nagayama D Br J Ophthalmol; 2008 Dec; 92(12):1642-7. PubMed ID: 18782798 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Boscia F; Parodi MB; Furino C; Reibaldi M; Sborgia C Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1224-32. PubMed ID: 16525824 [TBL] [Abstract][Full Text] [Related]
7. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Kim SW; Oh J; Oh IK; Huh K Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297 [TBL] [Abstract][Full Text] [Related]
14. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors. Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment. Lee NY; Kim KS Korean J Ophthalmol; 2008 Sep; 22(3):194-6. PubMed ID: 18784450 [TBL] [Abstract][Full Text] [Related]
16. Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy. Lee PY; Kim KS; Lee WK Jpn J Ophthalmol; 2009 Jan; 53(1):52-56. PubMed ID: 19184311 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Boscia F; Furino C; Sborgia L; Reibaldi M; Sborgia C Am J Ophthalmol; 2004 Dec; 138(6):1077-9. PubMed ID: 15629318 [TBL] [Abstract][Full Text] [Related]
18. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy]. Cornut PL; Quaranta-El Maftouhi M; Mauget-Faÿsse M J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817 [TBL] [Abstract][Full Text] [Related]